SEC Tracker
Get the app

TRex Bio TRXB

TRex Bio reports ownership

Ownership stake disclosure by PFIZER INC

Form
Schedule 13G
Filed
Importance
Routine
  1. Filed by PFIZER INC. on Oct 16, 2026
  2. Address of issuer: 269 East Grand Avenue, Suite 300, South San Francisco, CA
  3. PFIZER INC. is a Delaware, US entity
  4. Joint filing agreement with PFIZER VENTURES (US) LLC

Written from the Schedule 13G on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when TRex Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX